Introduction
The standard dialysis time is 8 h, three sessions per week.
The original long haemodialysis (HD) technique has Cuprophan artificial kidneys are used. The 1 m2 Kiil dialysers been maintained unchanged since the opening of the initially used for all patients have been progressively replaced Tassin Unit 28 years ago [1] . This technique provides by flat-plate or hollow-fibre Cuprophane disposable dialysers a high dose of dialysis (mean Kt/V=1.85) and facilit-(surface area 1.1-1.7 m2). These presently are used for >70% ates an adequate calorie and protein intake [ In most patients, tight control of blood pressure (BP) buffer is now used in 30% of the patients. The dialysate flow is achieved without the need for antihypertensive med-is 500 ml/min, the blood flow 220 ml/min. The blood access ication [2] . The incident population case mix shows used for dialysis in 75% of the patients is an arteriovenous an important trend toward older, weaker patients, with fistula. In the last few years, 15% of the patients have been high co-morbidity. The mortality and the morbidity using a central venous catheter and 10% a Thomas femoral on our long HD are better than usually reported. A shunt. major factor responsible for the good long-term sur-
The patients are requested to eat a varied diet unrestricted in proteins with a large calorie intake. They are asked not vival seems to be the tight control of blood pressure.
to add salt to their food. However, the use of cheese, a staple
The purpose of this report is to describe the long The overall HD experience of this population amounts to 5560 patient years. Up to admission time, all had been treated on 'conventional' mmHg. The evolution of pre-dialysis MAP and postdialysis (∏5 h three times a week) during 6 months or more.
All were converted to our 3×8 h schedule. When they arrived dialysis weight in the 60 first months of dialysis is in the unit, 55 of them needed regular antihypertensive reported in Figure 1 . An initial mean weight loss of treatment.
2 kg leads to a rapid decrease in BP. At that point, Actuarial survival rates were calculated using the the patient eats more, build lean and fat body mass Kaplan-Meier [6 ] method. The difference between series was and BP continues to decrease slowly. estimated by the log rank test. The limit of significance was set at 5%. We have analysed the effect of BP control on Survival and mortality patient survival using the Kaplan-Meier method. This was achieved by splitting the 685 patients who actually started The Kaplan-Meier survival analysis of all 876 patients their maintenance HD treatment in Tassin into two equal ( Table 3) nephritis, interstitial nephritis and polycystic kidney The acute morbidity evaluation was based on the analysis disease; the worst in diabetes mellitus. Among 308 of intradialytic morbidity. Intradialytic events, more spe-patients starting treatment with cardiovascular antecifically hypotensive episodes, were looked for in the unit's cedents, the survival is also significantly shorter than computer database where each dialysis session is individually in the 568 patients free of such antecedents. entered and validated by the physician in charge of the ward.
The overall population crude mortality has increased Hypotensive episodes were defined as any BP drop needing since this treatment schedule was initiated. This trend the nurse's intervention leading to a reduction of ultrafiltraobserved in five calendar cohorts differing in demotion or to a saline perfusion.
The long-term morbidity was assessed by the number and graphy and co-morbidity is reported in Table 4 . When adjusting for age, cause of renal failure and co-morbidity, mortality of the five calendar cohorts is not significantly different. This suggests that the trend increases steadily due to the growing age and incidence of high risk causes of CRF. to a worsening mortality is fully explained by the change in case mix. The standardized mortality (SMR)
Cox model analysis of patient survival is reported in Table 6 . The age at the start of HD, cause of renal ratio and Cox analysis confirm this.
Although the SMR computed by Wolfe's method failure and cardiovascular antecedents are patientrelated factors which heavily impact on mortality. varies slightly from year to year ( Table 5) , it shows that the patient mortality remains 2-3 times less in Among treatment-related factors, the pre-dialysis MAP is the most powerful predictor of mortality. For each Tassin than in the US. The expected number of deaths 1 mmHg increment of pre-dialysis MAP, the risk of proportion of cardiovascular deaths. When mortality is analysed in terms of number of deaths per 1000 death increases by 3.9% (39% for 10 mmHg). The risk of death is inversely and significantly linked to serum patient years and compared with the only available comparable French series [9], the only substantial albumin, and to Babb's index. In contrast, Kt/V urea, square metre hours per week and PCR do not appear difference is the much lower cardiovascular mortality in Tassin (19.9 vs 43.6 cardiovascular deaths per 1000 to be linked to mortality in this series.
The Kaplan-Meier survival curve of the two MAP patient years). subgroups of patients is reported in Figure 2 . The mortality was significantly less in the lower MAP Morbidity subgroup, (P=0.003). Furthermore, in this subgroup, Acute intradialytic morbidity data are reported in the cardiovascular mortality was lower (12.7 deaths vs Table 7 . The number of incidents observed in Tassin 28.1 per 1000 patient years at risk, P<0.001) than in during 8 and 5 h sessions is compared with reports of the slightly higher mean pre-dialysis MAP subgroup.
a French and an Italian registry [12,13]. The incident Cardiovascular causes of death, including unexoccurrence rate, in particular hypotension, is lower plained sudden deaths, are the most common in this using a longer session time. series (38% of total ), followed by infection (19%),
The hospitalization rate over the whole observation cancer (10%) and other causes. The proportion of the period gives an estimate of the population morbidity.
different causes of deaths is not different from what is
The mean number of hospitalizations is 1.07 per patient observed in other series [9-11], except for a lower per year, with a mean duration of 10.6 days per year. However, the hospitalization rate varies widely with patients factors. Diabetic patients have more days of hospitalization per year than non-diabetic patients (17.5 vs 6.8 days/year, P<0.001); the same is true for patients starting dialysis with atheroma antecedents compared with patients free of such antecedents (16.8 vs 6.4, P<0.001). The numbers of days spent in hospital per year is also correlated positively with age (P<0.01) and with mean pre-dialysis BP (P<0.001), and correlated negatively with mean pre-dialysis serum albumin (P<0.001).
The effects of changing the dialysis session time are reported in Figure 3 . After 3 months of long dialysis, dose was raised. Today, many forms of dialysis are used throughout the world. The weekly dialysis time varies between 6 h [24] and 56 h [28] , with advocated standard Kt/V from 1.0 to 1.8 [29] .
The comparison of patient survival between different countries or units is confusing due to the large number of non-treatment-related factors. The survival comparison using the standardized mortality ratio adjusts for age, race and cause of CRF. The 2 to 3-fold lower mortality observed in Tassin than in corresponding USRDS age-, race-and CRF aetiology-adjusted groups of patients is probably explained by the larger dialysis dose and/or time used. The mortality of Tassin patients compared with a series of French HD patients with comparable co-morbidity and transplant rate was lower (52.4 vs 99.8 deaths per 1000 patient years, P<0.001). This difference was explained mainly by the lower cardiovascular mortality. Kt/V has become the yardstick of dialysis adequacy. Can one attribute the success of the Tassin HD method exclusively to the very high dose of Kt/V provided? Cross-sectional Fig. 3 . Pre-dialysis blood pressure and post-dialysis weight in 103 epidemiological data suggest that mortality on dialysis patients switched from 3×5 h (for >6 months) to 3×8 h/week. decreases with the delivered Kt/V: Japan reports the lowest dialysis mortality and the highest mean Kt/V, with an initial reduction of weight, the mean pre-the US has the highest mortality and the lowest mean dialysis MAP decreased from 119 (162/98 mmHg) to Kt/V, Europe is intermediate in mortality and in 100 mmHg (136/82 mmHg). Antihypertensive medica-delivered Kt/V. Longitudinal epidemiological data are tions were discontinued in all but one patient. This more convincing: the reduction of delivered Kt/V in initial phase is followed by an anabolic period in the the US has been followed by an increasing mortality following year. Post-dialysis weight increases then by between 1985 and 1989, and conversely, the increase a mean 2.5 kg. This increase in weight correlated with in delivered Kt/V between 1990 and 1995 has been an increased appetite and serum pre-dialysis creatinine. followed by a reduction in the gross mortality [30] .
Several groups [31] [32] [33] have also reported a clear survival improvement by increasing the delivered dose
Discussion
of dialysis, as expressed by Kt/V. On the other hand, the shape of the Kt/V doseclinical response curve seems to some American nephThe 10 first years of empirical development of maintenance dialysis led to an almost universally accepted long rologists to be sufficiently uncertain to justify the very expensive HEMO study underway [34] . In addition time schedule two or three times per week. The gold standard was defined in 1975 [14] as 3×8 h per week reports of rather poor survival in spite of a high delivered Kt/V, or our own Cox analysis results, on a 1 m2 Kiil dialyser. At that time, blood pressure control was achieved by ultrafiltration without the suggest that urea Kt/V should be used rather to delineate a minimal dialysis dose [35] than to target need for antihypertensive medications in 90% of patients [15] [16] [17] [18] . In the early 1970s, the middle molec-the optimal dialysis in the way in which Hakim defines it: 'the dose above which no further improvement of ule hypothesis [19] made it theoretically possible to decrease the dialysis session time. This was proven morbidity and mortality can be expected' [36 ] .
The session time does more than being factored in feasible in 1973 [20] . Shortened (5 h) dialysis rapidly became the standard mode of dialysis delivery. The the Kt/V formula. A specific role of dialysis time on clinical results is a reasonable possibility [37] [38] [39] [40] . It schedules were shortened further after Gotch produced a mechanistic re-analysis [5] of the results of the increases the clearance rate of a wide spectrum of solutes larger than urea, and of solutes, such as phosNational Cooperative Dialysis Study, proposed the Kt/V concept, and suggested that above a Kt/V 1.0, phate, characterized by a slower transcellular shift rate.
A long dialysis reduces the chances of intradialytic no further improvement in clinical results should be expected. High efficiency [21, 22] and high flux dialysis events, especially hypotension [41] . It is less unphysiological [42] and it reduces the hazard of operational [23] allowed the dialysis session time to be reduced down to 2 h per session [24] . Some authors [25, 26 ] underdelivery of dialysis; in fact, the shorter the dialysis, the more difficult the dose delivery [43] . pointed out the limitations and potential danger of such shortened forms of dialysis. However, it was only Long dialysis allows for an adequate nutrition. Nutrition does not depend exclusively on an adequate after the 1989 Dallas meeting [27] showed that the mortality of dialysis patients was worringly high in the Kt/V allowance [44] . A longer schedule with very few diet prescriptions and medications allows for a large US that the issue of survival as a function of dialysis protein and calorie intake. Switching the patients from Amazingly, after >20 years of short dialysis practice we know of no report demonstrating that BP can be 5 to 8 h sessions was followed by an increase in dry weight. The increase in haematocrit (all blood trans-well controlled by this form of dialysis. Conversely, a long session time may not suffice to control BP, as fusions being stopped and without erythropoietin), urea and creatinine, while the blood pressure remained illustrated by the recent reports of Pierratos et al. [53] showing that some patients remain hypertensive and normal, confirms that the increase in weight corresponds to a true lean body mass increase and not to a need antihypertensive medication although they are dialysed for 56 h per week. saline load.
Even more importantly, long HD allows for tight In summary, the length of a particular patient's dialysis session should be determined by whichever is BP control. Our group has reported the good BP control achieved with long HD [1,2,45]. We stated longer, the time necessary to deliver an adequate dose of dialysis, or the time needed to remove enough fluid earlier that most patients on long HD back in the 1970s were normotensive without medication. This is and to control BP without the need for antihypertensive medications. The adequacy of dialysis depends of no longer the case in short HD. Several groups have pointed out the poor BP control on dialysis in recent the additive effect of these conditions, but neither is sufficient by itself. years [26, [46] [47] [48] while dialysis session had been shortened. It is our conviction that this is due mostly
Could new regimens, using sophisticated ultrafiltration techniques and large dialysis doses, allow the to the poor control of extracellular volume ( ECV ) as expressed by the dry weight [49] . Obviously, in recent dialysis duration to be shortened without giving up control of BP? This might be a challenge for the future. years, ECV control has been either neglected [50] or has become more difficult to achieve using excessively However, the evolution of the patient case mix towards older, weaker patients more sensitive to acute changes shortened sessions.
Reducing the session time increases the number of in volume will limit the practical opportunities to achieve this target. hypotensive episodes ( Table 7) ; this, in turn, has, several consequences. The nurse cannot achieve the prescribed dry weight because hypotensive episodes References necessitate the ultrafiltration rate to be reduced, saline to be given or the patient to be disconnected prema- thirsty, so that they put on more interdialytic weight. As a result, the patient becomes salt overloaded and The limit of ultrafiltration is no longer set by the 9. Degoulet P, Legrain M, Reach I, Aimé F, Devriès C, Rojas P, machine but by the patient's refilling capacity and by Can BP be controlled using short dialysis schedules?
